RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 69 filers reported holding RAPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,782 | -11.1% | 15,751 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $294,544 | +1.9% | 15,751 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $289,031 | +5.7% | 15,751 | +14.1% | 0.00% | 0.0% |
| Q4 2022 | $273,339 | -17.7% | 13,805 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $332,148 | +40.9% | 13,805 | +6.9% | 0.00% | +50.0% |
| Q2 2022 | $235,772 | -2.8% | 12,919 | +17.1% | 0.00% | 0.0% |
| Q1 2022 | $242,506 | -5.1% | 11,028 | +58.5% | 0.00% | 0.0% |
| Q4 2021 | $255,567 | +18.3% | 6,958 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $216,046 | -2.3% | 6,958 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $221,195 | +28.6% | 6,958 | +30.3% | 0.00% | 0.0% |
| Q3 2020 | $171,980 | +11.0% | 5,341 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $154,996 | – | 5,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |